Sutro Biopharma OverviewSutro Biopharma Operating Income
Operating Income for STRO.
Quarterly Operating Income
$-29656000.00
↓ 56.72% YoY
As of Mar 31, 2026
Annual Operating Income (TTM)
$-115117000.00
↓ 54.02% YoY
Trailing 12 months ending Mar 31, 2026